Commentary
What Inning Are We In? (First of a Series)
That’s the perennial question that leading direct lenders addressed last week on a panel moderated by your correspondent at the…
Read MoreFast Food
McDonald’s reported surprisingly strong earnings for the first quarter. An RBC piece last week said the burger giant’s results were…
Read MoreSpotlight on Healthcare – A Special Industry Report (Last of a Series)
We close our special healthcare series with a discussion of risk. “Increased risk is one of the primary concerns we…
Read MoreSpotlight on Healthcare – A Special Industry Report (Seventh of a Series)
We caught up recently with a banker friend – a veteran of the healthcare industry – to ask him for…
Read MoreSpotlight on Healthcare – A Special Industry Report (Sixth of a Series)
So far in our healthcare series, we’ve shown a sampling of private equity and advisory perspectives. This week we get…
Read MoreSpotlight on Healthcare – A Special Industry Report (Fifth of a Series)
One of the most interesting features of the new healthcare landscape is the evolving relationship between patients and doctors. As…
Read MoreSpotlight on Healthcare – A Special Industry Report (Fourth of a Series)
“Everyone is fighting for the primary care patient right now.” So said the CEO of a large independent physician practice…
Read MoreSpotlight on Healthcare – A Special Industry Report (Third of a Series)
News last week that Walmart was hooking up with Humana sent waves through the healthcare and retail world. Disruption has…
Read MoreSpotlight on Healthcare – A Special Industry Report (Second of a Series)
We continue our special series on healthcare with a look this week at how the sector is playing out in…
Read MoreSpotlight on Healthcare – A Special Industry Report (First of a Series)
The private equity firm Platinum Equity announced last week they had offered to buy Johnson & Johnson’s blood glucose monitoring…
Read More